CAMPBELL DAVID ALAN (Chief Executive Officer) sold 2.8% of their position (8.07K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $110.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/2/2026ACC: 0001864158-26-000002
DirectorOfficer· Chief Executive Officer
Since Jun 2021
+426.63K
Net shares
Net buyer
$110.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
434.70K acquired · 8.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.07K
Price / share
$13.73
Trade value
$110.83K
% of position
2.8%
1/2/2026
293.05K→284.98K
Common Stock
Direct
Shares
+96.60K
Price / share
—
Trade value
—
% of position
33.9%
1/2/2026
284.98K→381.58K
Total
Net shares
+88.53K
Net value
-$110.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −8.07K | $13.73 | $110.83K | 2.8% | 293.05K | 284.98K |
| Common Stock Direct | 1/2/2026 | A · Award | +96.60K | — | — | 33.9% | 284.98K | 381.58K |
| Total | +88.53K | -$110.83K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
338.10K shares
Shares
+338.10K
Strike price
13.65
Held after
338.10K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock338.10K shares | 1/2/2026 | A · Award | +338.10K | 13.65 | — | 338.10K |